We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

Global Viral Transport Medium Market Driven by Increasing Prevalence of Infectious Diseases

By LabMedica International staff writers
Posted on 25 Aug 2022
Print article
Image: The global VTM market is expected to grow at a CAGR of 3.51% during 2022-2027 (Photo courtesy of Pexels)
Image: The global VTM market is expected to grow at a CAGR of 3.51% during 2022-2027 (Photo courtesy of Pexels)

Viral transport medium (VTM) assumed importance globally when the new H1N1 influenza virus was identified, causing the world's first flu pandemic in more than 40 years. Since then, it has been used majorly by hospitals, labs, and academic/research institutes for transporting viral samples across the research and clinical value chain. During the transport, the virus, if present, in the sample specimen should remain intact until the testing is completed. More recently, the sudden onset of the COVID-19 pandemic significantly boosted the demand for transport medium products and related kits. With the fast spread of the COVID-19 virus, many countries prioritized diagnostic testing for quick diagnosis of the virus, fuelling an exponential increase in the demand for VTM kits for sample collection from suspected COVID-19 patients. Other viral infections, such as influenza, herpes, varicella, respiratory syncytial virus, and viral infectious diseases, also demand quick diagnosis in which VTM kits play a vital role in the collection, preservation, and transportation of specimens. As a result, the global VTM market is expected to grow at a CAGR of 3.51% during 2022-2027, driven by the increasing prevalence of infectious diseases.

These are the latest findings of Research and Markets (Dublin, Ireland), the world’s largest market research store.

VTM kits are constantly in demand due to the increasing prevalence of infectious diseases. The rising prevalence of viral infectious diseases has fueled an increase in the use of VTM kits. Some of the viral infectious diseases are COVID-19, influenza virus, enterovirus D68, herpes, varicella, RSV, etc. For diagnosing these diseases, the collection of samples, preservation, and transportation is required, with VTM kits being the most prominently used solutions by practitioners.

The demand for viral transport increased exponentially during the COVID-19 pandemic. The rise in COVID-19 testing across the world led to an increase in the consumption rate of VTM test kits. Millions of COVID-19 tests were done daily from June 2020 to January 2022, which proved to be a major turning point for the VTM market. With academic/research institutes intensifying their experiments for developing vaccines and mass testing to stop the spread of COVID-19 globally, vendors also increased their manufacturing capacities and produced billions of VTM kits. The companies have been focusing on innovation and developing kits containing double-ended flocked swabs, vials, antibiotics, and other items that inhibit microbial contamination.

In addition, with the continuous increase in seasonal flu cases, manufacturers are also manufacturing viral transport for influenza tests, owing to influenza-related morbidity and mortality in many countries. Efforts to improve the diagnostic rate and accuracy of viral infectious diseases continue to drive the VTM market growth as this requires laboratory testing of clinical specimens to identify the virus, viral antigens, and antibodies. In addition, a rapid increase in the aging population, rise in the number of people undergoing various voluntary surgeries and other factors have also accelerated the requirement for various diagnostic tests that involve the use of VTM kits.

Geographically, North America accounts for the largest share of the global VTM market due to a high number of laboratory tests conducted during the pandemic, presence of biopharma companies, large number of laboratories, well-developed healthcare services, and research studies carried out in the region. Influenza viral infections continue to increase in the African, North America, and Asia Pacific regions, which will require quick diagnosis and the need for collection, preservation, and transportation of specimens, thereby driving the growth of the global VTM market.


Platinum Supplier
Xylazine Immunoassay Test
Xylazine ELISA
Gold Supplier
Procalcitonin Test
POCT Fluorescent Immunoassay Analyzer
Gold Supplier
Spinal Fluid Cell Count Control

Print article


Clinical Chemistry

view channel
Image: A module with eight micro-devices, complete with microfluidic channels and drive motors (Photo courtesy of U.S Department of Energy)

Highly Sensitive pH Sensor to Aid Detection of Cancers and Vector-Borne Viruses

Understanding the acidity or alkalinity of substances through pH measurement is crucial in many fields, from environmental monitoring to healthcare product safety. In many cases, these measurements must... Read more

Molecular Diagnostics

view channel
Image: The PrismRA blood test helps target best treatments for patients with rheumatoid arthritis (Photo courtesy of Scipher Medicine)

Groundbreaking Rheumatoid Arthritis Blood Test Predicts Treatment Response

Rheumatoid arthritis (RA), an autoimmune disease affecting joints and other systems in the body, impacts millions globally. Typically, the initial biologic treatment involves anti-inflammatory drugs from... Read more


view channel
Image: The QScout hematology analyzer has received US FDA 510(k) clearance (Photo courtesy of Ad Astra Diagnostics)

First Rapid-Result Hematology Analyzer Reports Measures of Infection and Severity at POC

Sepsis, a critical medical condition that arises as an extreme response to infection, poses a significant health threat. It occurs when an infection triggers a widespread inflammatory response in the body.... Read more


view channel
Image: PointCheck is the world’s first device for non-invasive white cell monitoring (Photo courtesy of Leuko Labs)

World’s First Portable, Non-Invasive WBC Monitoring Device to Eliminate Need for Blood Draw

One of the toughest challenges for cancer patients undergoing chemotherapy is experiencing a low count of white blood cells, also known as neutropenia. These cells play a crucial role in warding off infections.... Read more


view channel
Image: Current testing methods for antibiotic susceptibility rely on growing bacterial colonies in the presence of antibiotics (Photo courtesy of 123RF)

Rapid Antimicrobial Susceptibility Test Returns Results within 30 Minutes

In 2019, antimicrobial resistance (AMR) was responsible for the deaths of approximately 1.3 million individuals. The conventional approach for testing antimicrobial susceptibility involves cultivating... Read more


view channel
Image: AI methods used in satellite imaging can help researchers analyze tumor images (Photo courtesy of Karolinska Institutet)

AI Approach Combines Satellite Imaging and Ecology Techniques for Analysis of Tumor Tissue

Advancements in tumor imaging technology have significantly enhanced our ability to observe the minute details of tumors, but this also brings the challenge of interpreting vast amounts of data generated... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.